Tirzepatide for beginners: what TikTok gets right and wrong

What did @annj624 actually say?

Honestly, this one is difficult to assess cleanly. The transcript is heavily garbled, likely the result of auto-captioning struggling with audio quality. What we can piece together: @annj624 describes herself as a tirzepatide beginner, says she is at 15mg, and repeatedly references dividing or splitting that dose. She mentions a 5-to-6-week timeframe and seems to be walking through her dosing math for a follower named Joy.

The core claim appears to be that she is starting tirzepatide at 15mg and dividing it into smaller units, possibly 5mg increments. That reading matters a lot clinically, so let's be clear about uncertainty here: the transcript does not let us confirm exactly what she is doing. But the 15mg figure is repeated often enough to treat as intentional.

Does the science back this up?

Starting tirzepatide at 15mg is not how the drug is meant to be used, and the clinical evidence is pretty firm on this. The SURMOUNT-1 trial (Jastreboff et al., 2022, NEJM) used a structured escalation starting at 2.5mg weekly, stepping up every four weeks. The 15mg dose in that trial was the maximum maintenance dose reached after months of titration, not a starting point.

The reason for slow titration is not arbitrary caution. GIP and GLP-1 dual agonism at high doses causes significant gastrointestinal side effects including nausea, vomiting, and diarrhea. SURMOUNT-1 data showed that even with careful escalation, roughly 4.3% of participants discontinued due to GI adverse events. Starting at the ceiling dose would almost certainly amplify those risks substantially.

Splitting a vial of tirzepatide, if that is what she is describing, also raises separate concerns about sterility, accurate measurement, and concentration math, especially with compounded versions where concentration can vary by pharmacy.

What did they get wrong (or right)?

If she is genuinely beginning tirzepatide at 15mg without prior titration, that is a significant departure from established dosing protocols and not something supported by clinical data. The SURMOUNT program did not test a high-dose cold-start approach, and there is no peer-reviewed evidence suggesting it is safe or effective as a beginner strategy.

What she may have gotten accidentally right: if she is splitting a 15mg vial into 5mg doses across multiple weeks, that could be a rough approximation of a lower starting dose. But the math only works if the vial concentration and measurement are handled correctly, which requires training and precision most people are not getting from a TikTok comment reply.

It is also worth noting that compounded tirzepatide is not equivalent to FDA-approved Zepbound or Mounjaro. Concentration, purity, and sterility standards differ, and patients using compounded versions need extra care around dosing accuracy.

What should you actually know?

Tirzepatide is a powerful drug with a well-studied titration schedule for good reasons. The approved starting dose is 2.5mg weekly for four weeks, followed by gradual increases. That schedule exists because the SURMOUNT trials showed it reduces the severity of side effects while still delivering meaningful weight loss outcomes.

If you are a beginner on tirzepatide, your starting dose and escalation plan should come from a licensed prescriber who knows your health history, not from a TikTok video about someone else's experience. Individual variation in response is real. What works without incident for one person can cause serious GI distress or other complications in another.

Splitting vials or improvising doses outside of a prescriber's guidance introduces additional risk. If you are using a compounded formulation, ask your pharmacy for the exact concentration in writing and confirm your measurement method with a clinician before injecting anything.